{
    "type": "ETF",
    "ucits": true,
    "fund_name": "AMUNDI GLOBAL BIOENERGY ESG SCREENED UCITS ETF USD Acc",
    "investment_objective": "Track the Bloomberg BioEnergy ESG Index with ESG screening, minimizing tracking error",
    "primary_asset_class": "Equity",
    "geographic_focus": "International, with significant US, Finland, Denmark, Italy, France, Germany exposure",
    "replication_method": "physical",
    "swaps": false,
    "derivatives": false,
    "leverage": false,
    "inverse": false,
    "complex_factors": [],
    "classification": "non-complex",
    "supporting_data": "The ETF is a UCITS-compliant equity ETF that physically replicates the Bloomberg BioEnergy ESG Index by direct investment in underlying securities. The KIID and PRIIPs KID explicitly state the use of direct replication as the primary method, with derivatives only used for operational purposes such as managing inflows/outflows or minor index exposure adjustments, not as an inherent part of the investment strategy. There is no mention of synthetic replication, swap agreements, total return swaps, or counterparty risk related to derivatives. The fund does not employ leverage, inverse exposure, or capital protection mechanisms. The risk profile is moderate (5/7), reflecting market risk in the bioenergy equity sector, with no complexity flags such as contingent bonds or structured products. Costs are straightforward with a single ongoing charge of 0.35%, no performance fees, and no swap or derivative fees. The factsheet confirms physical replication and no synthetic or swap usage. The index tracked is a standard ESG screened equity index without complex derivative overlays or structured features. Therefore, under MiFID II criteria, this ETF is classified as non-complex."
}